Extracorporeal membrane oxygenation (ECMO)
OtherECMO utilization in patient with malignancy and/or history of hematopoietic stem cell transplant.
NCT Number: NCT07712835
This was an observational study, with a descriptive and comparative portion. The descriptive analysis, a large single center experience, examined bleeding complications, infectious rates, and survival outcomes in patients under 18 years old with an underlying oncologic diagnosis and/or hematopoietic stem cell transplant on Extracorporeal membrane oxygenation (ECMO). In a small multicenter cohort, the comparative analysis evaluated survival outcomes in this population with respiratory failure in the presence and absence of ECMO. Children's Mercy Kansas City served as the ECMO cohort; Cincinnati Children's Hospital Medical Center served as the matched non-ECMO cohort.
Looking for future studies?
Notify Me4 week–17 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
ECMO utilization in patient with malignancy and/or history of hematopoietic stem cell transplant.
Time frame: Admission until hospital discharge, average of 46 days
Children's Mercy Hospital Kansas City
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07016685
ARDS, ECMO Outcomes
Amiens, France
View Trial DetailsNCT04471961
Familial Cancer, Hematologic Diseases
Montpellier, Occitanie, France
View Trial DetailsNCT07592039
Acute Respiratory Distress Syndrome, Lung Diseases
Wenzhou, Zhejiang, China
View Trial DetailsNCT05164016
Cancer, Cellular Therapy
Memphis, Tennessee, United States
View Trial Details